Internationalization and technological leapfrogging in the pharmaceutical industry
Internationalization is a useful strategy for gaining firm-specific technological advantages especially during periods of technological discontinuity as the pharmaceutical industry illustrates. The antibiotics revolution in the 1940s saw laggard US firms scrambling to gain capabilities in antibiotics. The possibilities of non-chemical routes to new drug discovery in the 1990s saw Indian generic drug manufacturers attempting to develop new drug discovery capabilities. This article compares the leapfrogging strategies adopted by US and Indian firms and shows that in both periods internationalization strategies were central to the technological strategies of both groups of firms. Copyright 2009 , Oxford University Press.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 18 (2009)
Issue (Month): 2 (April)
|Contact details of provider:|| Postal: Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK|
Fax: 01865 267 985
Web page: http://icc.oupjournals.org/
|Order Information:||Web: http://www.oup.co.uk/journals|
When requesting a correction, please mention this item's handle: RePEc:oup:indcch:v:18:y:2009:i:2:p:295-323. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Oxford University Press)or (Christopher F. Baum)
If references are entirely missing, you can add them using this form.